Health Equity Crisis: Black Adults Hospitalized for Heart Failure Nearly 14 Years Earlier Than White Counterparts image
3 min read

Health Equity Crisis: Black Adults Hospitalized for Heart Failure Nearly 14 Years Earlier Than White Counterparts

Pharm'Up
A groundbreaking study by Northwestern Medicine investigators, published in the Journal of the American College of Cardiology,...
Read More Read more about Health Equity Crisis: Black Adults Hospitalized for Heart Failure Nearly 14 Years Earlier Than White Counterparts
Empowering the Front Line: How Pharmacists Can Revolutionize Immunization Access for Vulnerable Cancer Patients image
2 min read

Empowering the Front Line: How Pharmacists Can Revolutionize Immunization Access for Vulnerable Cancer Patients

Pharm'Up
Patients battling cancer are profoundly immunosuppressed due to their chemotherapy and other therapeutic regimens, placing them at...
Read More Read more about Empowering the Front Line: How Pharmacists Can Revolutionize Immunization Access for Vulnerable Cancer Patients
IMS 2025: On-Body Injector (OBI) Technology Streamlines Oncology Care, Enhancing Safety and Efficiency for Pharmacists and Nurses image
2 min read

IMS 2025: On-Body Injector (OBI) Technology Streamlines Oncology Care, Enhancing Safety and Efficiency for Pharmacists and Nurses

Pharm'Up
At the 22nd annual International Myeloma Society (IMS) meeting, Xavier Leleu, MD, PhD, a leading hematologist from...
Read More Read more about IMS 2025: On-Body Injector (OBI) Technology Streamlines Oncology Care, Enhancing Safety and Efficiency for Pharmacists and Nurses
Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes image
2 min read

Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes

Pharm'Up
Biolinq Inc. has achieved a significant milestone in diabetes management with the FDA granting De Novo classification...
Read More Read more about Biolinq Shine Receives Landmark FDA De Novo Classification as First Multi-Analyte Wearable for Type 2 Diabetes
Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma image
2 min read

Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma

Pharm'Up
New data presented at the 2025 International Myeloma Society Annual Meeting in Toronto, Canada, has revealed that...
Read More Read more about Anito-cel CAR T-Cell Therapy Delivers Deep, Durable Responses and High MRD-Negativity in Relapsed/Refractory Multiple Myeloma
PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia image
2 min read

PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia

Pharm'Up
A comprehensive new systematic review and meta-analysis published in Open Heart has affirmed the strong and sustained...
Read More Read more about PCSK9 Inhibitors, Including Inclisiran, Show Sustained and Significant Lipid Reduction in Familial Hypercholesterolemia

Read These Too

Pharmup 21
2 min read

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up